Vizora日本語

Shin Nippon Biomedical LaboratoriesSHIN NIPPON BIOMEDICAL LABORATORIES, LTD.2395東証プライムサービス業FY ending Mar 2026, consolidated, J-GAAP

Which Shin Nippon Biomedical Laboratories businesses make the profit?

Revenue by business segment, and the profit each one keeps.

Revenue by geography

Geographic revenue reported in annual filings

No geographic revenue breakdown was disclosed.

※ Segment figures include inter-segment sales and do not sum to the company total

Revenue and profit mix

FY ending Mar 2026

Revenue mix

Profit mix (profitable segments)

CRO Services accounts for 96% of revenue and 100% of profit.

Loss-making segments (excluded from profit bar)

Translational Research: -¥4.03B

Medipolis: -¥65.9M

US Asset Management: -¥1.5M

Calculated from disclosed figures; listed by margin. Difference = profit share − revenue share (percentage points). Segment revenues may include inter-segment sales and may not sum to company revenue.

Business growth × margin

X-axis: segment revenue CAGR. Y-axis: latest operating margin. Bubble size: revenue.

Bubble size represents latest revenue. Segments without a CAGR are placed at the left edge; their horizontal position is not a growth value. Color indicates positive or negative margin.

Segment history (JPY millions)

SegmentRevenue CAGRFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
CRO Services+16.7%5y16,94429.7%23,92426.5%25,66127.4%31,51523.0%31,20522.1%
Translational Research+53.8%5y12-6192.9%16-5339.7%12-21161.9%54-6795.5%106-3818.2%
Medipolis+6.9%5y528-3.4%601-33.9%478-53.3%470-89.8%717-9.2%
Other+15.8%5y26415.7%54920.2%30029.4%329-8.1%3134.2%
US Asset ManagementN/A———46-131.6%184-0.8%

Top: revenue. Bottom: operating margin.

Sources

Show source documents (6)

  • EDINET (FSA Japan)

    有価証券報告書－第53期(2025/04/01－2026/03/31)

    ID S100YK732026-06-25Open

  • EDINET (FSA Japan)

    有価証券報告書－第52期(2024/04/01－2025/03/31)

    ID S100W81X2025-06-27Open

  • EDINET (FSA Japan)

    有価証券報告書－第51期(2023/04/01－2024/03/31)

    ID S100TS9X2024-06-25Open

  • EDINET (FSA Japan)

    有価証券報告書－第50期(2022/04/01－2023/03/31)

    ID S100R8752023-06-28Open

  • EDINET (FSA Japan)

    有価証券報告書－第49期(令和3年4月1日－令和4年3月31日)

    ID S100OK5K2022-06-29Open

  • EDINET (FSA Japan)

    有価証券報告書－第48期(令和2年4月1日－令和3年3月31日)

    ID S100LVCO2021-06-30Open

Extracted from XBRL: 55 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image